‘1 Strong and 2 Medium’ positions in Celebrex generic market
In the market of ‘Celebrex(generic name: celecoxib), a selective COX-2 inhibitor anti-inflammatory drug, which was recognized as the most competitive market due to approximately 100 generic products launched, Chong Kun Dang has acquired a prior advantage.
In addition, ‘Celebrex’ of Pfizer Korea,...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
